Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 128 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1271 9.6 months Metastatic uveal melanoma 4 Immunotherapy
Memorial Sloan-Kettering Cancer Center United States 10/2013
Treatment Details: Patients: This study involved 39 metastatic uveal melanoma patients with a median age of 61 years, 59% of whom were male. Treatment: Patients were treated with the immune therapy agent
 
1272 9.6 months Metastatic Malignant Melanoma 4 Chemotherapy
Yonsei University College of Medicine Korea 2/2015
Treatment Details: Patients: This phase 2 study involved 30 metastatic malignant melanoma patients who had been previously treated with dacarbazine or temozolomide. The median patient age was 53 years and 60
 
1273 9.5 months Non-Squamous NSCLC 4 Chemotherapy
Institute of Biomedical Research and Innovation Japan 6/2015
Treatment Details: Patients: This phase 2 study involved 28 advanced non‑squamous non‑small cell lung cancer patients who had not received prior chemotherapy. The median patient age was 75 years
 
1274 9.5 months Liver Cancer 5 Biologic therapy
Samsung Medical Center Korea 12/2014
Treatment Details: Patients: This phase 2 study involved 70 hepatocellular carcinoma patients with an average age of 55.4 years; 85.7% were male. Treatment: Patients received biologic therapy with refamet
 
1275 9.5 months Advanced melanoma 4 Biologic therapy
Chemotherapy
Churchill Hospital United Kingdom 2/2014
Treatment Details: Patients: This phase 2 study involved advanced melanoma patients with the wild-type BRAF gene who were divided into two different treatment groups. Group A consisted of 41 patients with a m
 
1276 9.5 months Squamous cell NSCLC 4 Chemotherapy
University of Pittsburgh Cancer Institute United States 9/2013
Treatment Details: Patients: This study involved squamous cell non-small-cell lung cancer patients who were divided into two separate treatment groups. Group A consisted of 229 patients with a median age of
 
1277 9.5 months Metastatic colorectal cancer 5 Biologic therapy
Chemotherapy
National University Hospital Singapore 4/2011
Treatment Details: Patients: This study involved 123 metastatic colorectal cancer patients who had been previously treated with irinotecan. The median age was 56 years and 59.3% were male. Treatment: Pa
 
1278 9.5 months Advanced hepatocellular carcinoma 3 Biologic therapy
Karmanos Cancer Institute United States 5/2012
Treatment Details: Patients: This study involved 27 patients with advanced hepatocellular cancer with a median age of 60 years; 74% were male. Treatment: Patients were treated with a combination of two bi
 
1279 9.5 months Advanced NSCLC 5 Biologic therapy
Winship Cancer Institute, Emory University United States 9/2012
Treatment Details: Patients: This phase 2 study involved advanced non-small-cell lung cancer patients who were divided into two separate treatment groups. Group A consisted of 94 patients with a median age o
 
1280 9.5 months Advanced or recurrent NSCLC 5 Chemotherapy
University of Torino Italy 11/2002
Treatment Details: Patients: This Phase III study involved a total of 607 patients with advanced (stage IIIB or IV or recurrent) non-small cell lung cancer. Patients were divided into three groups. Group A c
 
Page 128 of 187  | Previous Page  | Next Page